title: Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome.
abstract: OBJECTIVE
  To determine mRNA expression differences in genes involved in signalling and modulating sensory fatigue, and muscle pain in patients with chronic fatigue syndrome (CFS) and fibromyalgia syndrome (FM) at baseline, and following moderate exercise.
  
  
  METHODS
  Forty-eight patients with CFS only, or CFS with comorbid FM, 18 patients with FM that did not meet criteria for CFS, and 49 healthy controls underwent moderate exercise (25 min at 70% maximum age-predicted heart rate). Visual-analogue measures of fatigue and pain were taken before, during and after exercise. Blood samples were taken before and 0.5, 8, 24 and 48 h after exercise. Leucocytes were immediately isolated from blood, number coded for blind processing and analyses and flash frozen. Using real-time, quantitative PCR, the amount of mRNA for 13 genes (relative to control genes) involved in sensory, adrenergic and immune functions was compared between groups at baseline and following exercise. Changes in amounts of mRNA were correlated with behavioural measures and functional clinical assessments.
  
  
  RESULTS
  No gene expression changes occurred following exercise in controls. In 71% of patients with CFS, moderate exercise increased most sensory and adrenergic receptor's and one cytokine gene's transcription for 48 h. These postexercise increases correlated with behavioural measures of fatigue and pain. In contrast, for the other 29% of patients with CFS, adrenergic α-2A receptor's transcription was decreased at all time-points after exercise; other genes were not altered. History of orthostatic intolerance was significantly more common in the α-2A decrease subgroup. FM-only patients showed no postexercise alterations in gene expression, but their pre-exercise baseline mRNA for two sensory ion channels and one cytokine were significantly higher than controls.
  
  
  CONCLUSIONS
  At least two subgroups of patients with CFS can be identified by gene expression changes following exercise. The larger subgroup showed increases in mRNA for sensory and adrenergic receptors and a cytokine. The smaller subgroup contained most of the patients with CFS with orthostatic intolerance, showed no postexercise increases in any gene and was defined by decreases in mRNA for α-2A. FM-only patients can be identified by baseline increases in three genes. Postexercise increases for four genes meet published criteria as an objective biomarker for CFS and could be useful in guiding treatment selection for different subgroups.
authors: Department of Anesthesiology The Brain Institute Department of Neurobiology and Anatomy Department of Exercise and Sport Science, University of Utah, Salt Lake City, UT 84132, USA. alan.light@hsc.utah.edu
authors: A R
authors: AR
authors: Light
authors: L
authors: L
authors: Bateman
authors: D
authors: D
authors: Jo
authors: R W
authors: RW
authors: Hughen
authors: T A
authors: TA
authors: Vanhaitsma
authors: A T
authors: AT
authors: White
authors: K C
authors: KC
authors: Light
references: Pain. 2003 Dec;106(3):229-239
references: 14659506
references: Arch Intern Med. 2003 Jul 14;163(13):1530-6
references: 12860574
references: QJM. 2008 Dec;101(12):961-5
references: 18805903
references: Pharmacogenomics. 2006 Apr;7(3):387-94
references: 16610949
references: Ann Intern Med. 1994 Dec 15;121(12):953-9
references: 7978722
references: J Clin Pathol. 2005 Aug;58(8):826-32
references: 16049284
references: J Pain. 2009 May;10(5):542-52
references: 19411061
references: Physiol Behav. 2007 Dec 5;92(5):963-8
references: 17655887
references: Arch Gen Psychiatry. 2006 Nov;63(11):1267-72
references: 17088507
references: Dis Markers. 2002;18(4):193-9
references: 12590173
references: Brain Behav Immun. 2010 Oct;24(7):1209-17
references: 20447453
references: PLoS One. 2011 Feb 23;6(2):e17287
references: 21383843
references: J Transl Med. 2003 Dec 1;1(1):10
references: 14641939
references: Anesthesiology. 2010 Apr;112(4):1023-40
references: 20234303
references: Pain. 2003 Aug;104(3):567-577
references: 12927629
references: Arthritis Rheum. 2006 Oct;54(10):3351-62
references: 17009309
references: J Gen Intern Med. 2001 Jan;16(1):24-31
references: 11251747
references: PLoS One. 2009 Jun 05;4(6):e5805
references: 19503787
references: Arch Med Res. 2007 Apr;38(3):350-3
references: 17350488
references: Psychosom Med. 2003 Mar-Apr;65(2):268-75
references: 12651994
references: J Med Virol. 2009 Mar;81(3):473-80
references: 19152403
references: J Clin Pathol. 2008 Jun;61(6):730-9
references: 18057078
references: J Intern Med. 2005 Oct;258(4):388-90
references: 16164580
references: Clin Sci Mol Med. 1978 Jun;54(6):609-14
references: 657729
references: Int J Clin Exp Med. 2009;2(1):1-16
references: 19436827
references: J Infect Dis. 2008 Apr 15;197(8):1171-84
references: 18462164
references: Neuro Endocrinol Lett. 2007 Aug;28(4):456-62
references: 17693979
references: Autoimmun Rev. 2009 Feb;8(4):287-91
references: 18801465
references: Pharmacogenomics. 2006 Apr;7(3):395-405
references: 16610950
references: Mol Med. 2008 Sep-Oct;14(9-10):599-607
references: 18596870
references: Arthritis Rheum. 1990 Feb;33(2):160-72
references: 2306288
references: Behav Brain Funct. 2010 Dec 29;6:76
references: 21190576
references: Immunol Rev. 2008 Jun;223:114-31
references: 18613832
references: Clin Diagn Lab Immunol. 1999 Jan;6(1):6-13
references: 9874656
references: Pharmacogenomics. 2009 Jan;10(1):35-42
references: 19102713
references: Pharmacogenomics. 2006 Apr;7(3):475-83
references: 16610957
references: J Intern Med. 2011 Feb;269(2):182-8
references: 21073560
references: Genes Brain Behav. 2007 Mar;6(2):167-76
references: 16740143
references: J Intern Med. 2010 Apr;267(4):394-401
references: 20433583
references: BMC Microbiol. 2011 Jan 02;11:2
references: 21194495
references: Arthritis Care Res (Hoboken). 2010 May;62(5):600-10
references: 20461783
references: J Allergy Clin Immunol. 1998 Aug;102(2):222-30
references: 9723665
references: Behav Brain Funct. 2008 Sep 26;4:44
references: 18822143
references: J Transl Med. 2009 Nov 12;7:96
references: 19909538
references: J Neurophysiol. 2008 Sep;100(3):1184-201
references: 18509077
references: J Pain. 2009 Oct;10(10):1099-112
references: 19647494
references: BMC Med Genomics. 2009 Jun 25;2:38
references: 19555476
references: PLoS One. 2010 May 25;5(5):e10817
references: 20520837
references: Am J Med Sci. 2000 Jul;320(1):1-8
references: 10910366
references: Auton Neurosci. 2004 Jun 30;113(1-2):55-62
references: 15296795
references: Nat Rev Rheumatol. 2010 Dec;6(12):679-81
references: 21119716
references: Pharmacogenomics. 2006 Apr;7(3):375-86
references: 16610948
references: Am J Med Sci. 2003 Aug;326(2):55-60
references: 12920435
references: Ann N Y Acad Sci. 2009 Aug;1171:464-71
references: 19723090
references: Genomics. 2009 Oct;94(4):269-77
references: 19540336
references: Eur J Clin Invest. 2010 Jul;40(7):608-15
references: 20497461